By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Sony Responds to Microsoft, Acquires Bungie for $3.6B as M&A Activity Heats Up
The gaming industry has seen multiple large scales deals this month alone, including Microsoft's megadeal for Activision Blizzard. And, seemingly in response, rival Sony, picked up Bungie for $3.6 billion, a studio once owned by both Microsoft and Activision. The sector is reportedly on track to spend $150 billion on mergers and acquisitions just this year alone, a record-breaking total, according to investment firm Drake Star Partners. Michael Metzger, a partner at the firm specializing in technology, media, and communications, joined Cheddar to discuss the flurry of deals in the gaming space and what might be behind the hot M&A activity.
Unpacking the Neil Young vs. Joe Rogan Vaccine Misinformation PR Crisis on Spotify
After classic rocker Neil Young demanded removal of his music from Spotify over vaccine misinformation coming from The Joe Rogan Experience podcast, the platform made the decision to take down Young's songs and continue supporting Rogan with whom they have an exclusive contract. The move touched off a firestorm of controversy, leading to responses from both the streaming service and the podcasting host. Evan Nierman, CEO of Red Banyan Crisis PR, joined Cheddar to break down the latest on the fracas. "I think when [Spotify] initially said, we're not going to be commenting on that, that was a silly move because guess what? They did end up commenting about it, and nine times out of 10, when an organization says they're not going to be issuing a comment, they ultimately do," Nierman noted.
Tesla Reports Record Profits in Q4, Still Face Tough Questions Going Forward
Tesla reported record profits for an electric fourth quarter, but investors still have plenty of questions. The EV giant will not be releasing any new vehicles this year and provided no updates on its Cybertruck. Cheddar News was joined by Ed Butowsky, Chapwood Investments Managing Partner to go over Tesla's quarter and analyze its concerns going forward.
Apple Stock Jumps Following Earnings Report
Julius De Kempenaer, Senior Technical Analyst at Stockcharts.com, joined Cheddar News to break down what led to Apple's massive quarter, and what the future may hold for the tech giant as competition with Microsoft ramps up.
Load More